A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects
View/ Open
Author
Shen, Yan
Huang, Jinsha
Liu, Ling
Xu, Xiaoyun
Han, Chao
Zhang, Guoxin
Jiang, Haiyang
Li, Jie
Xiong, Nian
Wang, Tao
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.3389/fnagi.2016.00117Metadata
Show full item recordCitation
Shen, Y., J. Huang, L. Liu, X. Xu, C. Han, G. Zhang, H. Jiang, et al. 2016. “A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects.” Frontiers in Aging Neuroscience 8 (1): 117. doi:10.3389/fnagi.2016.00117. http://dx.doi.org/10.3389/fnagi.2016.00117.Abstract
Parkinson's Disease (PD) is a progressively neurodegenerative disorder, implicitly characterized by a stepwise loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) and explicitly marked by bradykinesia, rigidity, resting tremor and postural instability. Currently, therapeutic approaches available are mainly palliative strategies, including L-3,4-dihydroxy-phenylalanine (L-DOPA) replacement therapy, DA receptor agonist and deep brain stimulation (DBS) procedures. As the disease proceeds, however, the pharmacotherapeutic efficacy is inevitably worn off, worse still, implicated by side effects of motor response oscillations as well as L-DOPA induced dyskinesia (LID). Therefore, the frustrating status above has propeled the shift to cell replacement therapy (CRT), a promising restorative therapy intending to secure a long-lasting relief of patients' symptoms. By far, stem cell lines of multifarious origins have been established, which can be further categorized into embryonic stem cells (ESCs), neural stem cells (NSCs), induced neural stem cells (iNSCs), mesenchymal stem cells (MSCs), and induced pluripotent stem cells (iPSCs). In this review, we intend to present a compendium of preparation and application of multifarious stem cells, especially in relation to PD research and therapy. In addition, the current status, potential challenges and future prospects for practical CRT in PD patients will be elaborated as well.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885841/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:27662110
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)